Genedrive (FRA:D6M) Net Change in Cash : €3.10 Mil (TTM As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Genedrive Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Genedrive's Net Change in Cash for the six months ended in Jun. 2024 was €4.70 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 was €3.10 Mil.

Genedrive Net Change in Cash Historical Data

The historical data trend for Genedrive's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genedrive Net Change in Cash Chart

Genedrive Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Net Change in Cash

Get a 7-Day Free Trial

3.37

-6.57

2.35

-2.32

3.06

Genedrive Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Net Change in Cash	Get a 7-Day Free Trial															-1.99	-2.88	0.60	-1.60	4.70

Genedrive Net Change in Cash Calculation

Genedrive's Net Change in Cash for the fiscal year that ended in Jun. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-4.454	+	0.001	+	7.522	+	-0.012
	=	3.06

Genedrive's Net Change in Cash for the quarter that ended in Jun. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -1.596 + -0.002 + 6.293 + 0

= 4.70

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €3.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genedrive Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Genedrive's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Genedrive Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genedrive PLC (FRA:D6M) » Definitions » Net Change in Cash

Comparable Companies

LSE:LLAI LSE:ABDX LSE:PRM LSE:GENI LSE:VRCI LSE:AGL TMO DHR IDXX IQV A XSWX:LONN SHSE:603259 MTD ICLR ILMN WAT LH DGX RVTY

Traded in Other Exchanges

GDR:UK D6M:Germany

Address

48 Grafton Street, The Incubator Building, Manchester, GBR, M13 9XX

Website

http://www.genedriveplc.com

Genedrive PLC is a holding company engaged in the molecular diagnostics business. It operates in one operating segment named Diagnostics which is engaged in the Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and use in patient stratification (genotyping), pathogen detection, and other indications. Geographically the majority of the revenue is derived from the United Kingdom.

Genedrive Headlines

No Headlines